Riskpilot← Back to searchSign inGet full accessOWAK AB
ABActiveOrg 5593498495General medical practice activities · NACE 8621Est. 20210 employees
Revenue 2025
SEK 0
EBITDA margin
—
-59% vs 2024
Equity ratio
24.5%
Financial strength
Net profit 2025
SEK -3K
-103% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -13K | -59% |
| Net profit | SEK -3K | -103% |
| Total assets | SEK 625K | +4% |
| Equity | SEK 153K | -72% |
| Employees | 0 | — |
Legal name
OWAK AB
Org number
5593498495
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
30 november 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-01-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
OWAK AB skall, direkt eller genom hel eller delägda bolag, bedriva differentierade insatser, tjänster och konsultationer, utbildning och forskning inom företagshälsovård, hälso- och sjukvård, biomedicin, medicin och läkemedel samt musikalisk verksamhet. Ovanstående innefattar även föreläsningar och seminarier på organisations- grupp- och individnivå inom områdena arbetsliv, rehabilitering, hälsa och sjukvård samt därmed förenlig verksamhet. Företaget kan äga och förvalta värdepapper.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Staff expenses | — | — | −2 |
| EBITDA | −49 | −8 | −13 |
| Depreciation & amort. | — | — | — |
| EBIT | −49 | −8 | −13 |
| Net financials | 470 | 118 | 10 |
| Profit before tax | 421 | 110 | −3 |
| Tax | — | — | — |
| Net profit | 421 | 110 | −3 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 490 | 601 | 625 |
| Equity | 446 | 556 | 153 |
| Long-term debt | — | — | — |
| Short-term debt | 44 | 45 | 471 |
| Total debt | 44 | 45 | 471 |
EBITDA margin
-1318800.0%
This company
15.8%
Market median
-8346935% vs market
20232025
Equity ratio
24.5%
This company
38.2%
Market median
-36% vs market
20232025
Return on equity
-1.8%
This company
18.4%
Market median
-110% vs market
20232025
Net profit margin
-276700.0%
This company
8.1%
Market median
-3416149% vs market
20232025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20232025
Debt / equity
3.08×
This company
0.62×
Market median
-397% vs market
20232025
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KA Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Former (4) | ||
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of OWAK AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karin Agneta Ohlsén Kühn | Chief Executive Officer | 0 companies |
| Lina Anna Elisabeth Nordström | Board of Directors | 0 companies |
| Wolfgang Herbert Kühn | Deputy Board Member | 0 companies |
| Lars Hugo Viking Rillner | Deputy Board Member | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |
| Mikaela Jenni Berglund | Deputy Board Member | 0 companies |